Terminal Complement Complex
The Terminal Complement Complex is a transmembrane pore-forming structure generated during the terminal phase of the complement cascade, distinguishing itself from other complement-derived products by mediating direct cytolysis through insertion into pathogen or host cell membranes.
628
Publications
40.5K
Citations
2.6K
Authors
713
Institutions
Publications per year
2017–2026
86
Parents
628
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
Peter Hillmen, Neal S. Young, Jörg Schubert et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text
Medicine, Hematology, Pharmacology +17
Debra Gershov, SunJung Kim, Nathan Brot et al. · The Journal of Experimental Medicine · 2000 · 695 citations · Full text
Life Sciences, Immunology, Pathology +17
Jan Torzewski, Michael Torzewski, David E. Bowyer et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1998 · 564 citations
1–5 of 628
2.6K
34
h-index
24
h-index
18
h-index
18
h-index
17
h-index
1–5 of 2.6K
713
Oslo University Hospital
Oslo, Norway
29 h-index
227 publications
20.4K citations

University of Oslo
Oslo, Norway
27 h-index
214 publications
16.1K citations
Nordland Hospital
Bodø, Norway
23 h-index
63 publications
3.5K citations

University of Maryland, Baltimore
Baltimore, United States
23 h-index
89 publications
6.4K citations
Heidelberg University
Heidelberg, Germany
20 h-index
65 publications
2.5K citations
Harvard University
Cambridge, United States
16 h-index
58 publications
6.4K citations

Brigham and Women's Hospital
Boston, United States
16 h-index
47 publications
5.2K citations
Norwegian University of Science and Technology
Trondheim, Norway
16 h-index
43 publications
1.7K citations
1–8 of 713
JI · 59 publications · 4K citations
40
h-index
Repository · 47 publications · 1.9K citations
28
h-index
CEI · 27 publications · 1.2K citations
20
h-index
PNAS · 17 publications · 2.2K citations
17
h-index
JBC · 16 publications · 1.6K citations
16
h-index
1–5